Clinical Trial Update: Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes

View source ↗

Summary

This update notes the completion of a clinical trial evaluating the efficacy and safety of ipragliflozin at 50 mg and 100 mg in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ipragliflozin (ipragliflozin)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED